{
  "_metadata": {
    "description": "Disease prevalence data for patient funnel estimation",
    "last_updated": "2024-12",
    "population_base": "United States",
    "sources": [
      "SEER Cancer Statistics Review",
      "American Cancer Society Cancer Facts & Figures 2024",
      "CDC WONDER Database",
      "NIH/NCI Epidemiology Data"
    ]
  },
  "oncology": {
    "NSCLC": {
      "annual_incidence": 200000,
      "prevalence_per_100k": 57,
      "notes": "~85% of all lung cancers",
      "stage_distribution": {
        "I": 0.17,
        "II": 0.07,
        "III": 0.27,
        "IV": 0.49
      },
      "histology_distribution": {
        "adenocarcinoma": 0.40,
        "squamous": 0.25,
        "large_cell": 0.10,
        "other": 0.25
      }
    },
    "SCLC": {
      "annual_incidence": 30000,
      "prevalence_per_100k": 9,
      "notes": "~15% of all lung cancers",
      "stage_distribution": {
        "limited": 0.33,
        "extensive": 0.67
      }
    },
    "breast_cancer": {
      "annual_incidence": 310000,
      "prevalence_per_100k": 130,
      "notes": "Female breast cancer only",
      "stage_distribution": {
        "0_I": 0.48,
        "II": 0.33,
        "III": 0.11,
        "IV": 0.06
      }
    },
    "colorectal_cancer": {
      "annual_incidence": 153000,
      "prevalence_per_100k": 38,
      "stage_distribution": {
        "I": 0.22,
        "II": 0.22,
        "III": 0.27,
        "IV": 0.22
      }
    },
    "melanoma": {
      "annual_incidence": 100000,
      "prevalence_per_100k": 33,
      "stage_distribution": {
        "I": 0.45,
        "II": 0.25,
        "III": 0.20,
        "IV": 0.06
      }
    },
    "multiple_myeloma": {
      "annual_incidence": 35000,
      "prevalence_per_100k": 10,
      "notes": "Median age at diagnosis 69 years"
    },
    "prostate_cancer": {
      "annual_incidence": 290000,
      "prevalence_per_100k": 100,
      "stage_distribution": {
        "localized": 0.75,
        "regional": 0.13,
        "distant_mCRPC": 0.08
      }
    },
    "ovarian_cancer": {
      "annual_incidence": 20000,
      "prevalence_per_100k": 11,
      "stage_distribution": {
        "I": 0.16,
        "II": 0.09,
        "III": 0.51,
        "IV": 0.24
      }
    },
    "pancreatic_cancer": {
      "annual_incidence": 65000,
      "prevalence_per_100k": 15,
      "stage_distribution": {
        "resectable": 0.10,
        "locally_advanced": 0.30,
        "metastatic": 0.60
      }
    },
    "hepatocellular_carcinoma": {
      "annual_incidence": 41000,
      "prevalence_per_100k": 10,
      "notes": "Often in setting of cirrhosis"
    },
    "renal_cell_carcinoma": {
      "annual_incidence": 82000,
      "prevalence_per_100k": 22,
      "histology_distribution": {
        "clear_cell": 0.70,
        "papillary": 0.15,
        "chromophobe": 0.05,
        "other": 0.10
      }
    },
    "bladder_cancer": {
      "annual_incidence": 83000,
      "prevalence_per_100k": 21,
      "stage_distribution": {
        "non_muscle_invasive": 0.70,
        "muscle_invasive": 0.20,
        "metastatic": 0.05
      }
    },
    "head_and_neck_cancer": {
      "annual_incidence": 66000,
      "prevalence_per_100k": 18,
      "hpv_positive_oropharyngeal": 0.70
    },
    "gastric_cancer": {
      "annual_incidence": 27000,
      "prevalence_per_100k": 7,
      "her2_positive": 0.20
    },
    "esophageal_cancer": {
      "annual_incidence": 22000,
      "prevalence_per_100k": 5,
      "histology_distribution": {
        "adenocarcinoma": 0.60,
        "squamous": 0.35,
        "other": 0.05
      }
    },
    "AML": {
      "annual_incidence": 21000,
      "prevalence_per_100k": 5,
      "notes": "Acute Myeloid Leukemia"
    },
    "CLL": {
      "annual_incidence": 21000,
      "prevalence_per_100k": 6,
      "notes": "Chronic Lymphocytic Leukemia"
    },
    "NHL": {
      "annual_incidence": 80000,
      "prevalence_per_100k": 24,
      "subtypes": {
        "DLBCL": 0.30,
        "follicular": 0.20,
        "marginal_zone": 0.10,
        "mantle_cell": 0.06,
        "other": 0.34
      }
    }
  },
  "demographics": {
    "us_population": {
      "total": 335000000,
      "age_distribution": {
        "0_17": 0.22,
        "18_44": 0.36,
        "45_64": 0.25,
        "65_plus": 0.17
      },
      "gender_distribution": {
        "male": 0.49,
        "female": 0.51
      }
    },
    "typical_ehr_database": {
      "notes": "Representative academic medical center",
      "patient_count_range": {
        "small": 100000,
        "medium": 500000,
        "large": 2000000
      }
    }
  },
  "comorbidities": {
    "diabetes": {
      "prevalence_per_100k": 11300,
      "notes": "Type 2 diabetes in adults"
    },
    "hypertension": {
      "prevalence_per_100k": 47000,
      "notes": "Adults with high blood pressure"
    },
    "cardiovascular_disease": {
      "prevalence_per_100k": 7000,
      "notes": "History of MI, stroke, or heart failure"
    },
    "chronic_kidney_disease": {
      "prevalence_per_100k": 15000,
      "stage_distribution": {
        "stage_1_2": 0.50,
        "stage_3": 0.35,
        "stage_4_5": 0.15
      }
    },
    "hepatic_impairment": {
      "prevalence_per_100k": 4500,
      "child_pugh_distribution": {
        "A": 0.60,
        "B": 0.30,
        "C": 0.10
      }
    },
    "autoimmune_disease": {
      "prevalence_per_100k": 8000,
      "notes": "Various autoimmune conditions requiring immunosuppression"
    },
    "HIV_positive": {
      "prevalence_per_100k": 350
    },
    "hepatitis_B": {
      "prevalence_per_100k": 300,
      "notes": "Chronic HBV infection"
    },
    "hepatitis_C": {
      "prevalence_per_100k": 400,
      "notes": "Many now cured with DAAs"
    }
  }
}
